文献类型：期刊文献

英文题名：Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis

作者：Zhang, Liyan[1,2,5];Bai, Yuping[1,2,5];Yan, Peijing[3,4];He, Tingting[1,2,5];Liu, Bin[5];Wu, Shanlian[6];Qian, Zhen[5];Li, Changtian[1];Cao, Yunshan[7];Zhang, Min[2]

第一作者：Zhang, Liyan;张陆阳;张利英;张莉云

通信作者：Zhang, M[1];Cao, YS[2]

机构：[1]Gansu Univ Chinese Med, Sch Basic Med, Lanzhou 730000, Peoples R China;[2]Gansu Prov Hosp, Dept Sci Res Off, Lanzhou 730000, Peoples R China;[3]Sichuan Univ, Dept Epidemiol & Hlth Stat, West China Sch Publ Hlth, Chengdu 610044, Sichuan, Peoples R China;[4]Sichuan Univ, West China Fourth Hosp, Chengdu 610044, Sichuan, Peoples R China;[5]940th Hosp Joint Logist Support Force Chinese Peo, Dept Pathol, Lanzhou 730050, Peoples R China;[6]Ganzhou Peoples Hosp, Dept Pathol, Ganzhou 341000, Peoples R China;[7]Gansu Prov Hosp, Dept Cardiol, Lanzhou 730000, Peoples R China

第一机构：甘肃中医药大学

通信机构：[1]corresponding author), Gansu Prov Hosp, Dept Sci Res Off, Lanzhou 730000, Peoples R China;[2]corresponding author), Gansu Prov Hosp, Dept Cardiol, Lanzhou 730000, Peoples R China.

年份：2021

卷号：26

期号：4

起止页码：897

外文期刊名：HEART FAILURE REVIEWS

收录：;Scopus(收录号：2-s2.0-85100589932);WOS:【SCI-EXPANDED(收录号:WOS:000654200200012)】；

基金：This study was supported by the National Natural Science Foundation of China (grant no. 81860059), the International Cooperation Exchange Project of Gansu Province (grant no. 18YF1WA046) granted to MZ and CAS `Light of West China' Program granted to MZ and YSC.

语种：英文

外文关键词：Chronic thromboembolic pulmonary hypertension; Balloon pulmonary angioplasty; Pulmonary endarterectomy; Efficacy; Safety; Systematic review and meta-analysis

摘要：Although balloon pulmonary angioplasty (BPA) and pulmonary endarterectomy (PEA) are effective in chronic thromboembolic pulmonary hypertension (CTEPH), the comparison of their efficacy and safety is still unclear. We identified studies through a systematic review of PubMed, Cochrane Library, and Embase and used a random effects meta-analysis model to synthesize estimates of weighted mean differences or combined effect size. In total, 54 studies were included in this meta-analysis. The survival rates at perioperative/in-hospital period, 2 years, and 3 years were 100%, 99%, and 97%, respectively, in BPA group and 93%, 90%, and 88%, respectively, in PEA group. The variation of 6-min walk distance was 141.80 m in BPA and 100.73 m in PEA when the follow-up was 1-6 months. At <1-month, 1-6-month, and >12-month follow-up, the changed results of mean pulmonary arterial pressure were - 18.31, - 17.00, and - 12.97 mmHg in BPA group and - 18.93, - 21.21, and - 21.35 mmHg in PEA group. At <1-month and 1-6-month follow-up, the changed values of pulmonary vascular resistance were - 542.24 and - 599.77 dyne center dot s center dot cm(-5) in PEA group and - 443.49 and - 280.00 dyne center dot s center dot cm(-5) in BPA group. In addition, there was more wide variety of complications in PEA group than in BPA group. BPA might have higher survival rate (perioperative/in-hospital period, 2-year and 3-year follow-up) and fewer types of complications compared with PEA. The improvement in exercise capacity (1-6-month follow-up) in the BPA group might be more pronounced than in PEA group. Moreover, PEA might be superior in improvement of hemodynamic parameters (<1-month, 1-6-month, and>12-month follow-up).